Nephros Stock Forecast - Double Exponential Smoothing

NEPH Stock  USD 2.01  0.02  1.01%   
The Double Exponential Smoothing forecasted value of Nephros on the next trading day is expected to be 1.99 with a mean absolute deviation of  0.07  and the sum of the absolute errors of 4.42. Nephros Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Nephros stock prices and determine the direction of Nephros's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Nephros' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Nephros' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Nephros' systematic risk associated with finding meaningful patterns of Nephros fundamentals over time.
Check out Historical Fundamental Analysis of Nephros to cross-verify your projections.
For more detail on how to invest in Nephros Stock please use our How to Invest in Nephros guide.
  
As of now, Nephros' Payables Turnover is increasing as compared to previous years. The Nephros' current Asset Turnover is estimated to increase to 1.26, while Inventory Turnover is projected to decrease to 2.35. . The Nephros' current Common Stock Shares Outstanding is estimated to increase to about 10.9 M, while Net Loss is forecasted to increase to (6.3 M).
Most investors in Nephros cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Nephros' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Nephros' price structures and extracts relationships that further increase the generated results' accuracy.
Double exponential smoothing - also known as Holt exponential smoothing is a refinement of the popular simple exponential smoothing model with an additional trending component. Double exponential smoothing model for Nephros works best with periods where there are trends or seasonality.

Nephros Double Exponential Smoothing Price Forecast For the 19th of April

Given 90 days horizon, the Double Exponential Smoothing forecasted value of Nephros on the next trading day is expected to be 1.99 with a mean absolute deviation of 0.07, mean absolute percentage error of 0.01, and the sum of the absolute errors of 4.42.
Please note that although there have been many attempts to predict Nephros Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Nephros' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Nephros Stock Forecast Pattern

Backtest NephrosNephros Price PredictionBuy or Sell Advice 

Nephros Forecasted Value

In the context of forecasting Nephros' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Nephros' downside and upside margins for the forecasting period are 0.02 and 5.39, respectively. We have considered Nephros' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
2.01
1.99
Expected Value
5.39
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Double Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Nephros stock data series using in forecasting. Note that when a statistical model is used to represent Nephros stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information CriteriaHuge
BiasArithmetic mean of the errors 0.0093
MADMean absolute deviation0.0749
MAPEMean absolute percentage error0.0271
SAESum of the absolute errors4.4177
When Nephros prices exhibit either an increasing or decreasing trend over time, simple exponential smoothing forecasts tend to lag behind observations. Double exponential smoothing is designed to address this type of data series by taking into account any Nephros trend in the prices. So in double exponential smoothing past observations are given exponentially smaller weights as the observations get older. In other words, recent Nephros observations are given relatively more weight in forecasting than the older observations.

Predictive Modules for Nephros

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Nephros. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Nephros' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.091.805.20
Details
Intrinsic
Valuation
LowRealHigh
0.122.475.87
Details
2 Analysts
Consensus
LowTargetHigh
2.733.003.33
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Nephros. Your research has to be compared to or analyzed against Nephros' peers to derive any actionable benefits. When done correctly, Nephros' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Nephros.

Other Forecasting Options for Nephros

For every potential investor in Nephros, whether a beginner or expert, Nephros' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Nephros Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Nephros. Basic forecasting techniques help filter out the noise by identifying Nephros' price trends.

Nephros Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Nephros stock to make a market-neutral strategy. Peer analysis of Nephros could also be used in its relative valuation, which is a method of valuing Nephros by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Nephros Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Nephros' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Nephros' current price.

Nephros Market Strength Events

Market strength indicators help investors to evaluate how Nephros stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Nephros shares will generate the highest return on investment. By undertsting and applying Nephros stock market strength indicators, traders can identify Nephros entry and exit signals to maximize returns.

Nephros Risk Indicators

The analysis of Nephros' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Nephros' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting nephros stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Nephros in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Nephros' short interest history, or implied volatility extrapolated from Nephros options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Nephros offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nephros' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nephros Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nephros Stock:
Check out Historical Fundamental Analysis of Nephros to cross-verify your projections.
For more detail on how to invest in Nephros Stock please use our How to Invest in Nephros guide.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Complementary Tools for Nephros Stock analysis

When running Nephros' price analysis, check to measure Nephros' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nephros is operating at the current time. Most of Nephros' value examination focuses on studying past and present price action to predict the probability of Nephros' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nephros' price. Additionally, you may evaluate how the addition of Nephros to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Is Nephros' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nephros. If investors know Nephros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nephros listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.15)
Revenue Per Share
1.371
Quarterly Revenue Growth
0.272
Return On Assets
(0.09)
Return On Equity
(0.18)
The market value of Nephros is measured differently than its book value, which is the value of Nephros that is recorded on the company's balance sheet. Investors also form their own opinion of Nephros' value that differs from its market value or its book value, called intrinsic value, which is Nephros' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nephros' market value can be influenced by many factors that don't directly affect Nephros' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nephros' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nephros is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nephros' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.